{
    "id": "wrong_mix_random_publicationDate_00092_2",
    "rank": 91,
    "data": {
        "url": "https://www.lshtm.ac.uk/aboutus/people/connor.nicholas",
        "read_more_link": "",
        "language": "en",
        "title": "Nicholas Connor",
        "top_image": "https://www.lshtm.ac.uk/sites/default/files/favicons/favicon-32x32.png",
        "meta_img": "https://www.lshtm.ac.uk/sites/default/files/favicons/favicon-32x32.png",
        "images": [
            "https://www.lshtm.ac.uk/sites/default/files/styles/profile_full_image_elements/public/profile_image/3918.jpg?itok=Rn2hUrHW",
            "https://www.lshtm.ac.uk/sites/default/files/styles/thumbnail/public/2019-12/disability-confident-logo-transparent.png?itok=sPoHGNpV",
            "https://www.lshtm.ac.uk/sites/default/files/styles/thumbnail/public/2019-12/stonewall-logo-transparent.png?itok=RlHQsSX3",
            "https://www.lshtm.ac.uk/sites/default/files/styles/thumbnail/public/2021-12/access-able-logo-transparent_2.png?itok=_6Z5DhW1",
            "https://www.lshtm.ac.uk/sites/default/files/styles/thumbnail/public/2019-12/hr-excellence-in-research-logo-transparent_0.png?itok=wo0Y8dzQ",
            "https://www.lshtm.ac.uk/sites/default/files/styles/thumbnail/public/2019-12/living-wage-logo-transparent.png?itok=e7gKpLjt",
            "https://www.lshtm.ac.uk/sites/default/files/styles/thumbnail/public/2019-12/athena-swan-bronze-award-logo.png?itok=j82QMAhR"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/sites/default/files/favicons/apple-touch-icon.png",
        "meta_site_name": "LSHTM",
        "canonical_link": "https://www.lshtm.ac.uk/aboutus/people/connor.nicholas",
        "text": "Mr Nicholas Connor\n\nInt Head of Res Governance & Integrity\n\nNicholas has over 15 years of experience in cutting-edge Global Health research spanning diverse projects and settings. He has worked in the Indian Sub-Continent for many years as well as worked intensively on projects in a variety of East, West and Central African countries. He has deep experience with development, execution and management of complex projects. He has worked with the school since 2019 managing Quality Assurance for a number of clinical trials on Ebola and HPV vaccines. He has deep experience researching risk factors predisposing young children to community-acquired neonatal infections in South Asia and has been involved in child nutrition research and anthropometry. Nicholas is a team player and continues to help generate policy-changing research to optimally safeguard and improve the health of people in vulnerable conditions, to minimize threats to healthcare systems and to help build research capacity in LMICs.\n\nNicholas holds degrees with distinction in Global Health, Health Sciences and Ethics. He is focused on the set-up and maintenance of quality assurance, control and management systems to support Good Clinical Practices (ICH-GCP) during collaborative research in complex environments. He has a long-term interest in research ethics, development economics, data science, South-south partnerships and global health history.\n\nShare\n\nAffiliations\n\nExecutive Office\n\nProfessional Support Services\n\nTeaching\n\nNicholas has taught numerous short courses in Good Clinical Practice, Good Clinical Laboratory Practices, Issue Escalation within a clinical trial and has developed a suite of training materials related to these topics.\n\nFormerly, he developed and taught a course module in Barts and The London School of Medicine and Dentistry in Rheumatology for the undergraduate medical students while at Queen Mary University London.\n\nNicholas underwent course development training at Harvard School of Public Health to develop course content for the Global Health Delivery Project at Harvard University, this course was cancelled due to the 2008 financial downturn.\n\nHe remains interested in global health Pedagogy.\n\nResearch\n\nQuality Assurance in Global Health; Clinical Trials; Neonatal Infection; Ebola Virus Disease/viral hemorrhagic fevers;\n\nResearch Area\n\nClinical trials\n\nQuality improvement\n\nVaccines\n\nMedicine\n\nNutrition\n\nCapacity development\n\nDisease and Health Conditions\n\nSepsis\n\nMalnutrition\n\nHuman papillomavirus (HPV)\n\nEmerging infectious diseases\n\nCountry\n\nSierra Leone\n\nTanzania\n\nCongo\n\nMalawi\n\nGuinea\n\nBangladesh\n\nRegion\n\nSub-Saharan Africa (developing only)\n\nSouth Asia\n\nSelected Publications\n\nDelivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo\n\nKavunga-Membo, H; WATSON-JONES, D; Kasonia, K; EDWARDS, T; Camacho, A; Mambula, G; Tetsa-Tata, D; Choi, EM-L; Aboubacar, S; Brindle, H; ROBERTS, C; Manno, D; Faguer, B; Mossoko, Z; Mukadi, P; Kakule, M; Balingene, B; Mapendo, EK; Makarimi, R; Toure, O; Campbell, P; Mousset, M; Nsaibirni, R; Ama, IS; Janvier, KK; ... Muyembe-Tamfum, JJ.\n\n2024\n\nVaccines\n\nImmunogenicity and Safety of One-Dose Human Papillomavirus Vaccine Compared With Two or Three Doses in Tanzanian Girls (DoRIS): An Open-Label, Randomised, Non-inferiority Trial\n\nWATSON-JONES, D; Changalucha, J; WHITWORTH, H; Pinto, L; Mutani, P; Indangasi, J; Kemp, T; Hashim, R; Kamala, B; Wiggins, R; Songoro, T; CONNOR, N; Mbwanji, G; Pavon, MA; Lowe, B; Mmbando, D; KAPIGA, S; MAYAUD, P; De SanJosé, S; Dillner, J; HAYES, RJ; Lacey, CJ; Baisley, K;\n\n2023\n\nObstetrical & Gynecological Survey\n\nRisk factors for community-acquired bacterial infection among young infants in South Asia: a longitudinal cohort study with nested case-control analysis.\n\nCONNOR, NE; Islam, MS; Mullany, LC; Shang, N; Bhutta, ZA; Zaidi, AK M; Soofi, S; Nisar, I; Panigrahi, P; Panigrahi, K; Satpathy, R; Bose, A; Isaac, R; Baqui, AH; Mitra, DK; Sadeq-Ur Rahman, Q; Hossain, T; Schrag, SJ; Winchell, JM; Arvay, ML; Diaz, MH; Waller, JL; Weber, MW; Hamer, DH; Hibberd, P; ... Saha, SK.\n\n2022\n\nBMJ global health\n\nSafety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.\n\nMANNO, D; Bangura, A; Baiden, F; Kamara, AB; AYIEKO, P; Kallon, J; Foster, J; Conteh, M; CONNOR, NE; Koroma, B; Njie, Y; Borboh, P; Keshinro, B; Lawal, BJ; KROMA, MT; Otieno, GT; Deen, AT; CHOI, EM-L; BALAMI, AD; Gaddah, A; McLean, C; Luhn, K; Adetola, HH; Deen, GF; Samai, M; ... WATSON-JONES, D.\n\n2022\n\nThe Lancet. Infectious diseases\n\nImmunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.\n\nWATSON-JONES, D; Changalucha, J; WHITWORTH, H; Pinto, L; Mutani, P; Indangasi, J; Kemp, T; Hashim, R; Kamala, B; Wiggins, R; Songoro, T; CONNOR, N; Mbwanji, G; Pavon, MA; Lowe, B; Mmbando, D; KAPIGA, S; MAYAUD, P; De SanJosé, S; Dillner, J; HAYES, RJ; Lacey, CJ; BAISLEY, K;\n\n2022\n\nThe Lancet Global health\n\nInfectious aetiologies of neonatal illness in south Asia classified using WHO definitions: a primary analysis of the ANISA study.\n\nArvay, ML; Shang, N; Qazi, SA; Darmstadt, GL; Islam, MS; Roth, DE; Liu, A; CONNOR, NE; Hossain, B; Sadeq-Ur Rahman, Q; El Arifeen, S; Mullany, LC; Zaidi, AK M; Bhutta, ZA; Soofi, SB; Shafiq, Y; Baqui, AH; Mitra, DK; Panigrahi, P; Panigrahi, K; Bose, A; Isaac, R; Westreich, D; Meshnick, SR; Saha, SK; ... Schrag, SJ.\n\n2022\n\nThe Lancet Global Health\n\nValidation of community health worker identification of maternal puerperal sepsis using a clinical diagnostic algorithm in Bangladesh and Pakistan.\n\nLeFevre, AE; Mir, F; Mitra, DK; Ariff, S; Mohan, D; Ahmed, I; Sultana, S; Winch, PJ; Shakoor, S; CONNOR, NE; Islam, MS; El-Arifeen, S; Quaiyum, MA; Baqui, AH; Gravett, MG; Santosham, M; Bhutta, ZA; Zaidi, A; Saha, SK; Ahmed, S; Soofi, S; Bartlett, LA;\n\n2021\n\nJournal of global health\n\nSafety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.\n\nISHOLA, D; MANNO, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,\n\n2021\n\nLancet Infectious Diseases\n\nPartnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.\n\nBadio, M; Lhomme, E; Kieh, M; Beavogui, AH; Kennedy, SB; Doumbia, S; Leigh, B; Sow, SO; Diallo, A; Fusco, D; Kirchoff, M; Termote, M; Vatrinet, R; Wentworth, D; Esperou, H; Lane, HC; Pierson, J; Watson-Jones, D; Roy, C; D'Ortenzio, E; GREENWOOD, B; Chêne, G; Richert, L; Neaton, JD; Yazdanpanah, Y; ... PREVAC study team,\n\n2021\n\nTrials\n\nGlobal burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.\n\nWang, X; Li, Y; O'Brien, KL; Madhi, SA; Widdowson, M-A; Byass, P; Omer, SB; Abbas, Q; Ali, A; Amu, A; Azziz-Baumgartner, E; Bassat, Q; Abdullah Brooks, W; Chaves, SS; Chung, A; Cohen, C; Echavarria, M; Fasce, RA; Gentile, A; Gordon, A; Groome, M; Heikkinen, T; Hirve, S; Jara, JH; Katz, MA; ... Respiratory Virus Global Epidemiology Network,\n\n2020\n\nThe Lancet Global health\n\nSee more information"
    }
}